An Evaluation of High-Dose Medroxyprogesterone Acetate (MPA) Therapy in Women With Advanced Breast Cancer

British Journal of Cancer - United Kingdom
doi 10.1038/bjc.1984.184
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

High Dose Raloxifene in Patients With Advanced Breast Carcinoma

Breast Cancer Research
Cancer ResearchOncology
2000English

High Dose, Dose-Intensive Chemotherapy With Doxorubicin and Cyclophosphamide for the Treatment of Advanced Breast Cancer

British Journal of Cancer
Cancer ResearchOncology
1993English

Clinical Research Protocols for High-Dose Therapy for Breast Cancer

Cancer Control
MedicineOncologyHematology
1998English

High-Dose Chemotherapy in High-Risk Breast Cancer

Breast Cancer Research
Cancer ResearchOncology
2000English

Comparative Actions of Progesterone, Medroxyprogesterone Acetate, Drospirenone and Nestorone on Breast Cancer Cell Migration and Invasion

BMC Cancer
Cancer ResearchOncologyGenetics
2008English

Subcutaneous Depo-Medroxyprogesterone Acetate

Journal of Family Planning and Reproductive Health Care
2013English

Risk of Advanced-Stage Breast Cancer Among Older Women With Comorbidities

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2012English

Effect of Medroxyprogesterone Acetate on Vascular Inflammatory Markers in Postmenopausal Women Receiving Estrogen

Circulation
Cardiovascular MedicinePhysiologyCardiology
2002English

PCN121 Evaluation of Aromatase Inhibitor Utilization and Failure in Post-Menopausal Women With Advanced ER+/HER2- Breast Cancer

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy